The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials

被引:1225
作者
Moher D. [1 ]
Schulz K.F. [2 ]
Altman D.G. [3 ]
Lepage L. [4 ]
机构
[1] University of Ottawa, Thomas C. Chalmers Ctr. Syst. Rev., Ottawa, Ont.
[2] Dept. of Obstetrics, School of Medicine, University of North Carolina, Chapel Hill, NC
[3] ICRF Medical Statistics Group, Centre for Statistics in Medicine, Institute of Health Sciences, Oxford
[4] Thomas C Chalmers Ctr. Syst. Rev., Children's Hosp. E. Ont. Res. Inst., Ottawa, Ont. KIH 8LI
关键词
Flow Diagram; Consort Statement; Checklist Item; Primary Data Analysis; Inadequate Reporting;
D O I
10.1186/1471-2288-1-2
中图分类号
学科分类号
摘要
To comprehend the results of a randomized controlled trial (RCT), readers must understand its design, conduct, analysis and interpretation. That goal can only be achieved through complete transparency from authors. Despite several decades of educational efforts, the reporting of RCTs needs improvement. Investigators and editors developed the original CONSORT (Consolidated Standards of Reporting Trials) statement to help authors improve reporting by using a checklist and flow diagram. The revised CONSORT statement presented in this paper incorporates new evidence and addresses some criticisms of the original statement. The checklist items pertain to the content of the Title, Abstract, Introduction, Methods, Results and Discussion. The revised checklist includes 22-items selected because empirical evidence indicates that not reporting the information is associated with biasedestimates of treatment effect or the information is essential to judge the reliability or relevance of the findings. We intended the flow diagram to depict the passage of participants through an RCT. The revised flow diagram depicts information from four stages of a trial (enrolment, intervention allocation, follow-up, and analysis). The diagram explicitly includes the number of participants, for each intervention group, included in the primary data analysis. Inclusion of these numbers allows the reader to judge whether the authors have performed an intention-to-treat analysis. In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.
引用
收藏
页码:1 / 7
页数:6
相关论文
共 30 条
  • [1] Schulz K.F., Chalmers I., Hayes R.J., Altman D.G., Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA, 273, pp. 408-412, (1995)
  • [2] Moher D., Pham B., Jones A., Cook D.J., Jadad A.R., Moher M., Tugwell P., Does the quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?, Lancet, 352, pp. 609-613, (1998)
  • [3] Jadad A.R., Boyle M., Cunningham C., Kim M., Schachar R., Treatment of attention-deficit/hyperactivity disorder, Evidence Report/Technology Assessment No. 11 (Prepared by McMaster University under Contract No. 290-97-0017), (2000)
  • [4] Thornley B., Adams C.E., Content and quality of 2000 controlled trials in schizophrenia over 50 years, BMJ, 317, pp. 1181-1184, (1998)
  • [5] Hotopf M., Lewis G., Normand C., Putting trials on trial- the costs and consequences of small trials in depression: A systematic review of methodology, J Epidemiol Community Health, 51, pp. 354-358, (1997)
  • [6] Dickinson K., Bunn F., Wentz R., Edwards P., Roberts I., Size and quality of randomised controlled trials in head injury: Review of published studies, BMJ, 320, pp. 1308-1311, (2000)
  • [7] Begg C.B., Cho M.K., Eastwood S., Horton R., Moher D., Olkin I., Rennie D., Schulz K.F., Simel D.L., Stroup D.F., Improving the quality of reporting of randomized controlled trials: The CONSORT statement, JAMA, 276, pp. 637-639, (1996)
  • [8] Freemantle N., Mason J.M., Haines A., Eccles M.P., CONSORT: An important step toward evidence-based health care, Ann Intern Med, 126, pp. 81-83, (1997)
  • [9] Altman D.G., Better reporting of randomized controlled trials: The CONSORT statement, BMJ, 313, pp. 570-571, (1996)
  • [10] Schulz K.F., The quest for unbiased research: Randomized clinical trials and the CONSORT reporting guidelines, Ann Neurol, 41, pp. 569-573, (1997)